California State Teachers Retirement System Biomarin Pharmaceutical Inc Transaction History

California State Teachers Retirement System

  • $84.1 Billion
  • Q3 2024

A detailed history of California State Teachers Retirement System transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, California State Teachers Retirement System holds 266,667 shares of BMRN stock, worth $17.5 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
266,667
Previous 273,241 2.41%
Holding current value
$17.5 Million
Previous $22.5 Million 16.67%
% of portfolio
0.02%
Previous 0.03%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$69.02 - $93.84 $453,737 - $616,904
-6,574 Reduced 2.41%
266,667 $18.7 Million
Q2 2024

Aug 14, 2024
SELL
$74.43 - $92.22 $337,465 - $418,125
-4,534 Reduced 1.63%
273,241 $22.5 Million
Q1 2024

May 15, 2024
SELL
$83.81 - $99.0 $263,582 - $311,355
-3,145 Reduced 1.12%
277,775 $24.3 Million
Q4 2023

Feb 13, 2024
SELL
$76.22 - $98.51 $258,157 - $333,653
-3,387 Reduced 1.19%
280,920 $27.1 Million
Q3 2023

Nov 14, 2023
SELL
$85.07 - $94.48 $1.12 Million - $1.24 Million
-13,173 Reduced 4.43%
284,307 $25.2 Million
Q2 2023

Aug 21, 2023
SELL
$86.68 - $100.3 $357,381 - $413,536
-4,123 Reduced 1.37%
297,480 $25.8 Million
Q1 2023

May 09, 2023
SELL
$87.74 - $117.27 $232,598 - $310,882
-2,651 Reduced 0.87%
301,603 $29.3 Million
Q4 2022

Feb 14, 2023
BUY
$80.93 - $108.63 $251,530 - $337,622
3,108 Added 1.03%
304,254 $31.5 Million
Q3 2022

Nov 18, 2022
SELL
$82.16 - $96.94 $222,735 - $262,804
-2,711 Reduced 0.89%
301,146 $25.5 Million
Q2 2022

Aug 15, 2022
SELL
$71.48 - $86.85 $714 - $868
-10 Reduced -0.0%
303,857 $25.2 Million
Q1 2022

May 16, 2022
SELL
$74.28 - $92.69 $1.37 Million - $1.71 Million
-18,459 Reduced 5.73%
303,867 $23.4 Million
Q4 2021

Feb 15, 2022
BUY
$71.72 - $91.47 $459,151 - $585,590
6,402 Added 2.03%
322,326 $28.5 Million
Q3 2021

Nov 15, 2021
SELL
$74.77 - $85.47 $287,939 - $329,144
-3,851 Reduced 1.2%
315,924 $24.4 Million
Q2 2021

Aug 16, 2021
SELL
$75.51 - $84.79 $1.58 Million - $1.77 Million
-20,882 Reduced 6.13%
319,775 $26.7 Million
Q1 2021

May 18, 2021
BUY
$74.73 - $90.69 $179,202 - $217,474
2,398 Added 0.71%
340,657 $25.7 Million
Q4 2020

Feb 16, 2021
BUY
$72.61 - $90.2 $635,918 - $789,971
8,758 Added 2.66%
338,259 $29.7 Million
Q3 2020

Nov 17, 2020
BUY
$71.87 - $131.03 $529,538 - $965,429
7,368 Added 2.29%
329,501 $25.1 Million
Q2 2020

Aug 17, 2020
BUY
$79.55 - $124.22 $667,583 - $1.04 Million
8,392 Added 2.67%
322,133 $39.7 Million
Q1 2020

May 13, 2020
SELL
$71.37 - $96.85 $570,674 - $774,412
-7,996 Reduced 2.49%
313,741 $26.5 Million
Q4 2019

Feb 14, 2020
BUY
$64.27 - $86.37 $1.68 Million - $2.25 Million
26,082 Added 8.82%
321,737 $27.2 Million
Q3 2019

Nov 15, 2019
BUY
$67.4 - $85.11 $231,249 - $292,012
3,431 Added 1.17%
295,655 $19.9 Million
Q2 2019

Aug 14, 2019
BUY
$80.35 - $93.9 $455,986 - $532,882
5,675 Added 1.98%
292,224 $25 Million
Q1 2019

May 09, 2019
BUY
$84.2 - $98.62 $103,229 - $120,908
1,226 Added 0.43%
286,549 $25.5 Million
Q4 2018

Feb 13, 2019
BUY
$80.14 - $106.07 $344,762 - $456,313
4,302 Added 1.53%
285,323 $24.3 Million
Q3 2018

Nov 14, 2018
BUY
$93.92 - $105.72 $281 - $317
3 Added 0.0%
281,021 $27.3 Million
Q2 2018

Aug 14, 2018
BUY
$76.01 - $99.03 $308,600 - $402,061
4,060 Added 1.47%
281,018 $26.5 Million
Q1 2018

May 15, 2018
SELL
$77.67 - $92.63 $724,195 - $863,682
-9,324 Reduced 3.26%
276,958 $22.5 Million
Q4 2017

Feb 14, 2018
SELL
$80.76 - $95.13 $486,175 - $572,682
-6,020 Reduced 2.06%
286,282 $25.5 Million
Q3 2017

Nov 13, 2017
BUY
$80.6 - $94.95 $23.6 Million - $27.8 Million
292,302
292,302 $27.2 Million

Others Institutions Holding BMRN

# of Institutions
629
Shares Held
178M
Call Options Held
1.98M
Put Options Held
1.17M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.2B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email